alexa QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure.
Psychiatry

Psychiatry

Journal of Addiction Research & Therapy

Author(s): Perry R, De Pasquale CG, Chew DP, Aylward PE, Joseph MX

Abstract Share this page

Abstract BACKGROUND: The primary determinate for the indication of cardiac resynchronization therapy in symptomatic chronic heart failure currently is a prolonged QRS duration. This is based on the premise that a prolonged QRS duration is a marker of left ventricular (LV) dyssynchrony. Tissue synchronization imaging (TSI) is an emerging technology that uses tissue Doppler velocities to determine the time to peak velocity of regions of the ventricular myocardium. OBJECTIVES: Our objectives were to determine the prevalence of dyssynchrony in a cardiomyopathic population referred for echocardiography irrespective of QRS duration, to validate the novel technique of TSI in evaluation of mechanical LV dyssynchrony and to determine the accuracy of QRS duration in predicting significant LV dyssynchrony. METHODS: A total of 100 patients with significant LV dysfunction (Simpson's ejection fraction < or = 35\%) referred for echocardiography underwent TSI. Dyssynchrony was defined as a difference in time to peak contraction of greater than 105 milliseconds between opposing ventricular segments. RESULTS: Overall, 61 patients (61\%) demonstrated significant dyssynchrony, whereas 52\% had a QRS duration of greater than 120 milliseconds. Among those with a prolonged QRS duration, significant dyssynchrony was evident in 30 (58\%). However, dyssynchrony was also common among those with a narrow QRS duration (<120 milliseconds) (31 patients [65\%]). Of the 61 patients with dyssynchrony, 31 (51\%) would have been missed if QRS criteria were used alone. CONCLUSIONS: A substantial proportion of patients have dyssynchrony by TSI, but do not have a prolonged QRS duration. These patients may benefit from cardiac resynchronization therapy but on traditional criteria would be excluded from the therapy. Expanding the criteria for cardiac resynchronization therapy to include echocardiographic parameters may extend the benefit of this technology to a greater population in need. This article was published in J Am Soc Echocardiogr and referenced in Journal of Addiction Research & Therapy

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords